Wearable technology has been the latest and the most proactive gadget used by people these days. A new study found that it also comes in handy to assess the clinical status of people with late onset Pompe Disease.
The research titled “Mobility assessment using wearable technology in patients with late-onset Pompe disease” finds an extended function that can be put to use for people suffering. Pompe, a neuromuscular disorder, resulting from genetic mutation leading to impaired glycogen degradation and collection of toxic molecules. The disease can manifest as early as infancy or as late as old age. The loss of skeletal muscle strength eventually passages dependency on walking aids and wheelchairs.
Researchers from Sanofi Genzyme, in collaboration with PatientsLikeMe, an online support group, studied how the disease moved in late trigger patients. 17% of the total participants in the study needed ambulatory help and 38% required breathing assistance. They were provided with a wearable tracking device for a period of a week to monitor their movement. It was found that people with Pompe were less prone to be active than the general population but needed lesser medical or ambulatory assistance when compared to other degenerative chronic diseases.
There was also a strong association between age, diagnostic status and their dependency on a walking aid.
“This study illustrates a new approach to measure mobility in late-onset Pompe disease patients and establishes a framework for future outcomes data collection. With advancement in technology and integrated data systems, we anticipate that wearable technology linked with patient self-reports will enable better characterization of Pompe patients and aid physicians in clinical decision making,” the researchers said.